BSP Pharmaceuticals S.p.A. was glad to announce the future opening of a new suite Sterile 5 equipped to handle liquid and lyophilized vials and designed to be a unique manufacturing system specially projected for anticancer drugs, with the flexibility to manage small molecules and the complexity of ADC products. This suite will be the second bigger of the entire plant for its Lyo surface (2x215 sqf). This suite will be built under CLOSED RABS (cRABS), to have the highest level of sterility assurance and containment.
